Solutions by Sector

Explore the domains in which Orbogen Bio merges biological engineering with high-throughput experimentation to develop innovative solutions.

Industrial Biotechnology

Orbogen Bio possesses considerable expertise in the development and optimization of microbial strains, including bacteria, yeast, and filamentous fungi, aimed at the production of small molecules such as amino acids, vitamins, flavors, and antibiotics, as well as proteins like enzymes and food proteins. We systematically address critical properties such as product titer, product yield, and productivity to facilitate the development of commercially viable bioprocesses.

Large stainless steel bioreactor with control panel and internal sight windows showing bubbling liquid.

Agricultural Biotechnology

Symmetrical rows of young green plants with drip irrigation in a sunlit field.

Orbogen Bio facilitates the advancement of biological solutions for sustainable agriculture through the generation and optimization of microbes tailored for specific applications. Whether the production of biologically active compounds against pests or improving nitrogen fixation to minimize fertilizer usage, we equip stakeholders with the essential tools to design pertinent microorganisms.

Food Biotechnology

Orbogen Bio provides microbial non-GMO solutions to the food industry such as the engineering of strains producing enzymes for processing, as in cheese or bread manufacturing, or the production of nutritional ingredients. We are also experienced in strain optimization for precision fermentation, an area that is relevant for the future sustainable production of food.

Rustic wooden table set with artisan cheeses, yogurt bowls, milk, and bread in a sunny garden.

Pharmaceutical Biotechnology

Syringe and glass vial labeled ANTIBODY TREATMENT - 5 ML on a sterile metal tray.

Orbogen Bio contributes to the development of effective medicines through its high-throughput screening platform, which is utilized to analyze extensive libraries of biologics for their activity. Additionally, the company is equipped to support drug production, exemplified by its capability to generate highly productive cell lines or to enhance for example the synthesis of capsids for gene therapy applications.